|
|
||||||||
|
|
|||||||||
|
|
Oncology - Basic: Basic ScienceBiomarkers and Radiation Effects |
1 Dept. Nuclear Medicine, Technische Universitaet Muenchen, Munich, Germany 2 EC, JRC, Inst. Transuranium Elements, Karlsruhe, Germany
637
Objectives: To facilitate dosimetric calculations in
-emitter therapy, new concepts, preferably based on biological models, are needed. Since cytotoxicity of
-particles is due to induction of DNA double-strand breaks (DSBs), detection of DSBs should be a straightforward concept. At sites of DSBs histones H2AX are phosphorylated, resulting in
-H2AX. Using an antibody that specifically binds to
-H2AX, the numbers of DSBs can be correlated to the
-emitter activity applied. The aim of this study was to quantify DNA-DSBs in gastric cancer cells after incubation with 213Bi-immunoconjugates.
Methods: The monoclonal antibody d9MAb specifically binds to HSC45-M2 gastric cancer cells expressing mutant d9-E-cadherin. HSC45-M2 cells were incubated with different activity concentrations of tumor-specific 213Bi-d9MAb conjugates for 3 h (t
= 46 min). At different time points after incubation
-H2AX was detected using immunofluorescence and Western blotting.
Results: Incubation of HSC45-M2 cells seeded in chamber slides with 1.48 GBq/ml caused massive formation of
-H2AX foci in the nuclei of treated cells that were not observed in the neighboring chamber incubated with PBS only. Thus,
-emission during 213Bi decay is unable to induce DSBs while
-particles triggered massive DSBs. Phosphorylation of histone H2AX in HSC45-M2 cells could also be demonstrated via Western blotting. Induction of
-H2AX foci was dependent on 213Bi-d9MAb activity concentration.
Conclusions: Detection of DSBs via
-H2AX foci is a promising concept to evaluate cytotoxicity and to estimate doses in 213Bi-immunotherapy.
| ||||||||||||||||||||||||||||||||||||||